Xiangqiong Wen

机构：Nanchang University, Sun Yat-sen University, Affiliated Hospital of Southwest Medical University, First Affiliated Hospital of Sichuan Medical University, First Affiliated Hospital of Jiangxi Medical College, Key Laboratory of Guangdong Province, The First Affiliated Hospital, Sun Yat-sen University, Center for Clinical Research (United States), Shanghai Clinical Research Center, First Affiliated Hospital of Nanchang University

发表论文 15 篇 · 总被引 335 次 · h-index 9

代表论文

• Metabolism-regulated ferroptosis in cancer progression and therapy (2024 · Cell Death and Disease · 被引 78)
• Spironolactone Add-on for Preventing or Slowing the Progression of Diabetic Nephropathy: A Meta-analysis (2015 · Clinical Therapeutics · 被引 72)
• The c-MYC-WDR43 signalling axis promotes chemoresistance and tumour growth in colorectal cancer by inhibiting p53 activity (2022 · Drug Resistance Updates · 被引 53)
• Fatty acids in cancer chemoresistance (2023 · Cancer Letters · 被引 37)
• MAPK Signaling‐Mediated RFNG Phosphorylation and Nuclear Translocation Restrain Oxaliplatin‐Induced Apoptosis and Ferroptosis (2024 · Advanced Science · 被引 33)
• The relationship between coronary artery calcification and bone metabolic markers in maintenance hemodialysis patients (2023 · BMC Nephrology · 被引 17)